Clinical Trial Update: A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of ARRY-520 in advanced myeloid leukemia and myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• ARRY-520 (indisulam)

Snippet

Sponsor: Pfizer | Conditions: Advanced MDS, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED